Prognostic significance and molecular associations of CDKN2A (p16) promoter methylation and loss of expression in colorectal cancer

被引：0
作者：
Shima, Kaori
Nosho, Katsuhiko
Baba, Yoshifumi
Cantor, Mami
Giovannucci, Edward L.
Fuchs, Charles S.
Ogino, Shuji
机构：
来源：
CANCER RESEARCH | 2010年 / 70卷
关键词：
D O I：
10.1158/1538-7445.AM10-4639
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
4639
引用
收藏
页数：3
相关论文
共 50 条
  • [31] p16 inactivation by methylation of the CDKN2A promoter occurs early during neoplastic progression in Barrett's esophagus
    Bian, YS
    Osterheld, MC
    Fontolliet, C
    Bosman, FT
    Benhattar, J
    GASTROENTEROLOGY, 2002, 122 (04) : 1113 - 1121
  • [32] UVB-induced decrease of p16/CDKN2A expression in skin cancer patients
    Krähn, G
    Leiter, U
    Udart, M
    Kaskel, P
    Peter, RU
    PIGMENT CELL RESEARCH, 2001, 14 (03): : 201 - 205
  • [33] p16 Immunohistochemical Expression as a Surrogate Assessment of CDKN2A Alteration in Gliomas Leading to Prognostic Significances
    Geyer, Lucas
    Wolf, Thibaut
    Chenard, Marie-Pierre
    Cebula, Helene
    Schott, Roland
    Noel, Georges
    Guerin, Eric
    Pencreach, Erwan
    Reita, Damien
    Entz-Werle, Natacha
    Lhermitte, Benoit
    CANCERS, 2023, 15 (05)
  • [34] Comparing p16 and MTAP loss of expression in detecting CDKN2A homozygous deletion in pleomorphic xanthoastrocytoma
    Vizcaino, M. A.
    Mendoza, C. Zepeda
    Vaubel, R.
    Nguyen, A. T.
    Trejo-Lopez, J. A.
    Raghunathan, A.
    Jenkins, S.
    Jenkins, R.
    Giannini, C.
    BRAIN PATHOLOGY, 2023, 33
  • [35] Loss of p16 (CDKN2A) Expression Is Rare in Dedifferentiated Liposarcoma and Does Not Promote Tumor Progression
    Kang, Y.
    Horvai, A. E.
    MODERN PATHOLOGY, 2014, 27 : 19A - 19A
  • [36] CDKN2A/p16 evaluation in cytology specimens
    Xing, Juan
    Griffith, Christopher C.
    CANCER CYTOPATHOLOGY, 2023, 131 (11) : 672 - 676
  • [37] Associations of risk factors obesity and occupational airborne exposures with CDKN2A/p16 aberrant DNA methylation in esophageal cancer patients
    Ganji, S. Mohammad
    Miotto, E.
    Callegari, E.
    Sayehmiri, K.
    Fereidooni, F.
    Yazdanbod, M.
    Rastgar-Jazii, F.
    Negrini, M.
    DISEASES OF THE ESOPHAGUS, 2010, 23 (07) : 597 - 602
  • [38] Correlation of CDKN2A Promoter Methylation Status with Loss of p16 Expression in Atypical Spitz Nevi and Spitzoid Melanoma Using the Digital Droplet PCR (ddPCR) Method
    Rahi, Hamed
    Milosevic, Dragana
    Guo, Ruifeng
    Geiersbach, Katherine
    LABORATORY INVESTIGATION, 2023, 103 (03) : S428 - S429
  • [39] CDKN2A gene deletions and loss of p16 expression occur in osteosarcomas that lack RB alterations
    Nielsen, GP
    Burns, KL
    Rosenberg, AE
    Louis, DN
    AMERICAN JOURNAL OF PATHOLOGY, 1998, 153 (01) : 159 - 163
  • [40] CDKN2A and MTAP Deletions in Peritoneal Mesotheliomas: Correlation with Loss of p16 Protein Expression and Survival
    Krasinskas, A. M.
    Bartlett, D.
    Cieply, K.
    Dacic, S.
    MODERN PATHOLOGY, 2009, 22 : 136A - 136A
12345